Webinar Recordings
HRSA Delays Start of 340B Guidance
America's hospitals welcome today's announcement that the Health Resources and Services Administration intends to delay the compliance date by which certain hospitals participating in the 340B drug pricing program must meet agency guidance.
Key Resources
Related Resources
AHA Center for Health Innovation Market Scan